Charles W. Scarantino, MD, PhD
Founder and Chairman of the Board
Dr. Charles Scarantino is the principal founder and medical director of Sicel
Technologies and is responsible for conceiving the novel implantable sensor
technology platform. He is a radiation oncologist with Triangle Radiation
Oncology Services (TROS) practicing in the Rex Healthcare Cancer Center. Dr.
Scarantino received a PhD degree in cell physiology at St. John's University
and an MD from Bowman Gray School of Medicine.
Michael D. Riddle
President/CEO
Michael Riddle has more than 25 years of experience in the healthcare industry,
including the marketing and sales of both capital equipment and disposable
medical devices for Fortune 100 and startup phase medical companies. Most
recently, Mr. Riddle served as the executive vice president of sales, marketing
and business development for PharmaNetics Inc., where he was responsible for
establishing strategic alliances for distribution and product development.
Prior to PharmaNetics, Mr. Riddle was employed by American Home Products for
seven years in various positions including vice president of sales and
marketing for Sherwood Medical Devices.
H. Troy Nagle, MD, PhD
Co-Founder and Director
Dr. H. Troy Nagle is professor of electrical and computer engineering at North
Carolina State University, research professor of biomedical engineering at the
University of North Carolina at Chapel Hill, and a past president of the IEEE.
His primary interest is in the creation of medical instrumentation systems that
contain biologically important sensors; the sensor technology generated in his
laboratory served as the basis for early development efforts at Sicel
Technologies. Dr. Nagle received a PhD in electrical engineering from Auburn
University and an MD from the University of Miami.
Jonathan Gelles, PhD
Burton Advisors
Burton Advisers Ltd. (BAL) is a London-based financial advisory company
providing corporate and strategic consulting and fundraising services to the
worldwide healthcare industry. Established in 1996 under the chairmanship of
Dr. J. Gelles, BAL clients (predominantly North American) have interest in the
biopharmaceutical, biotechnology, medical device, drug delivery and drug
development arenas. BAL's funding activities, from the startup phase and
beyond, have covered both public and private corporations, though all
transactions have been conducted on a private placement basis.
Cheryl Sunderland
Adinvest AG
Adinvest AG is a Zurich based financial advisory and private equity investment
firm. Ms. Sunderland specializes in life sciences investments and advises
various international companies. Before joining Adinvest, Ms. Sunderland was
global vice president at ABB, the multinational engineering group, responsible
for Corporate Finance until 2000 and Value Services until 2002. Prior to
joining ABB in 1992, Ms. Sunderland was a founding managing director of SFS in
London, a financial services advisory firm specializing in leveraged buy-outs
and corporate reconstruction. Previously she was a director of Corporate
Finance at Elders Finance Group (now Fosters Brewing), arranging leveraged
buy-outs and mezzanine debt. Ms Sunderland co-established the London subsidiary
of Elders Finance Group after relocating from Australia where she was head of
Credit for the Group. Ms. Sunderland holds degrees from Stanford and Johns
Hopkins Universities.
|
OVERVIEW
BOARD
OF DIRECTORS